Systematic Review of Psychometric Instruments Used in Research with Psychedelics.
Alexandre Augusto de Deus Pontual, H G Senhorini, C M Corradi-Webster, L F Tófoli, D Daldegan-Bueno
Journal of Psychoactive Drugs 2023 DOI: 10.1080/02791072.2022.2079108 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Keywords | 5d-ac Meq30 Psychedelics Hallucinogens Instruments Psychometric |
| Citations | 37 |
| Key findings | Nine psychometric instruments are available for assessing subjective states induced by psychedelics, but many aspects of the experience remain unmeasured. |
Abstract
There has been a revival of research that studies the subjective effects of psychedelic drugs on humans. Areas of health science have been studying their possible therapeutic benefits, and psychological measurement instruments are being developed as the studies progress. However, these instruments currently suffer criticism regarding their number and evidence of psychometric quality. This study aims to review which psychometric instruments are available to assess subjective states induced by psychedelics. We systematically searched five databases (Web of Science, Academic Search Premier, EMBASE, CINAHL and PubMed) using psychometrics and psychedelics related terms identifying studies published from 1990 to 2021. Of 857 articles generated from the systematic-search, fifteen met our criteria and were included in the review, evaluating nine instruments: MEQ, 5D-ASC, HRS, PSI, EDI, CEQ, EBI, EDI and PIQ. Eight dealing with phenomenological aspects of the psychedelic experience and one as a screening tool for psychotic or manic episode. The purpose of each instrument, the number of items in each version, the type of scale and their elaboration process were described. The number of instruments used in psychedelic research is growing steadily, but there are still many other parts of the psychedelic experience that lack measurement.
Citations in the library
Cited by 33
- The Altered States Database: Psychometric data from a systematic literature review. Scientific Data November 23, 2022
- Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects. Frontiers in Psychiatry 2023
- A framework for assessment of adverse events occurring in psychedelic-assisted therapies Journal of Psychopharmacology July 31, 2024
- Dose-response relationships of LSD-induced subjective experiences in humans. Neuropsychopharmacology October 1, 2023
- The ego in psychedelic drug action – ego defenses, ego boundaries, and the therapeutic role of regression Frontiers in Neuroscience October 6, 2023
and 28 more in the library
Cites 40
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later Journal of Psychopharmacology May 30, 2008
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV) PLoS One August 31, 2010
and 35 more in the library